U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TEZEPELUMAB
RJ1IW3B4QX
US Approved Rx (2021)
First approved in 2021
General
Names
11
Classification
3
Identifiers
14
Subunits
4
Related Substances
1
TEZEPELUMAB
RJ1IW3B4QX
US Approved Rx (2021)
First approved in 2021
General
Approval Year
2021
460
Names
11
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
MEDI-19929
Preferred Name
English
TEZEPELUMAB
Official Name
English
TEZEPELUMAB [JAN]
Common Name
English
TEZEPELUMAB [USAN]
Common Name
English
MEDI-9929
Code
English
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Classification
3
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Agent Affecting Respiratory System
Pharmacologic Substance
[C1909]
Agent Affecting Respiratory System
[C78273]
Anti-asthmatic Agent
NCI_THESAURUS
C29712
Designated
ORPHAN DRUG
Designated
Treatment of Eosinophilic Esophagitis
FDA ORPHAN DRUG
839721
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Showing 1 to 3 of 3 entries
Previous
1
Next
Identifiers
14
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
EVMPD
SUB179650
PRIMARY
WIKIPEDIA
Tezepelumab
PRIMARY
SMS_ID
100000165774
PRIMARY
ChEMBL
CHEMBL3707229
PRIMARY
RXCUI
2587789
PRIMARY
Showing 1 to 5 of 14 entries
Previous
1
2
3
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
RJ1IW3B4QX
TEZEPELUMAB
